Govt bans serological test kits for TB diagnosis

Image
Press Trust of India New Delhi
Last Updated : Jan 24 2013 | 1:49 AM IST

"The central government is satisfied that the use of serodiagnostic test kits for diagnosis of tuberculosis are giving inconsistent and improper results leading to wrong diagnosis and their use is likely to involve risk to human beings and whereas safer alternatives are available," said a notification issued by the Ministry of Health and Family Welfare.

The Ministry held that "it is necessary and expedient to prohibit the manufacture, sale, distribution and use of the said test kits in public interest."

The test kits have been banned with immediate effect following exercise of powers conferred by Section 26A of the Drugs and Cosmetic Act, 1940.

The ban follows a negative policy statement issued by the WHO over commercial serodiagnostic tests for tuberculosis stating that "commercial serological tests provide inconsistent and imprecise findings resulting in highly variable values for sensitivity and specificity."

The government had also sent a warning to various states for not using the serodiagnostic tests due to their inaccurate results.

"There is no evidence that existing commercial serological assays improve patient-important outcomes, and high proportions of false-positive and false-negative results adversely impact patient safety. Overall data quality was graded as very low and it is strongly recommended that these tests not be used for the diagnosis of pulmonary and extra- pulmonary TB," the WHO policy statement concluded.

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 19 2012 | 7:36 PM IST

Next Story